Carol Hamilton leads a group of scientists with expertise in biology, computer science and computational biology. Members of the group lead or support research efforts in genomics, genome-wide association studies, phenotypes and environmental exposures, and have proficiency in systems architecture, web-based and responsive design, data management, software engineering, agent-based epidemiological modeling, and high-performance and cloud computing. Her team helps clients address basic and applied problems in biology and medicine and data science.
With training in genetics, biochemistry, and molecular biology, Dr. Hamilton has developed new technologies in bacterial genetics, agricultural biotechnology and high-throughput genomics. Her professional experience includes contributions to the development of data analysis pipelines, methods for analysis of complex genomic data (systems biology) and the development of data visualization tools that link genomic data to biochemical pathways.
Dr. Hamilton has demonstrated effective management of interdisciplinary research teams. She is currently the Principal Investigator for PhenX (consensus measures for Phenotypes and eXposures), a cooperative agreement funded by the National Human Genome Research Institute (NHGRI) and the National Institute on Drug Abuse (NIDA) of the National Institutes of Health. The PhenX Toolkit www.phenxtoolkit.org provides the biomedical community with a catalog of measures, and bioinformatics support, that together promote collaborative research and facilitate cross-study analysis.
